Most Popular Stories
- UnitedHealth reveals details of option back-dating settlement
- DOD, VA move to SOA architecture to build interoperable systems
- Social Security wants EMR access for disability determination
- Another attempt to halt Horizon BCBS of NJ's switch to for-profit
- Study: EMRs can cut paid malpractice settlements
- HHS: 60 percent of DME companies banned by Medicare may keep billing
- AHA survey: Negative profit margins for hospitals
- HHS: 60 percent of DME companies banned by Medicare may keep billing
- Healthcare on track to set record for mass layoffs
- DOD, VA move to SOA architecture to build interoperable systems
- Study: EMRs can cut paid malpractice settlements
- Signs of trouble in the Motor City
Poll
Featured Jobs
-
Oregon Asst. Nurse Manager/Day Surgery
StaffPointe, LLC - Springfield , OR -
Virginia Dialysis Registered Nurse
StaffPointe, LLC - north , VA -
California Physical Therapist
StaffPointe, LLC - Fresno , CA -
Colorado Labor/Surg RN Manager
StaffPointe, LLC - north , CO -
Georgia Invasive Cardiologist
StaffPointe, LLC - southeast coast , GA
Events
- Avaya Patient Payment Recovery Webinar
Thursday, December 11, 2008 1-2pm
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
Popular Topics
NIH official implicated in scandal
A report by investigators from the House Energy and Commerce Committee found that a prominent researcher at the National Institutes of Health received hundreds of thousands of dollars in payment from Pfizer. He received the cash in return for granting Pfizer access to human spinal fluid samples collected as part of a government project. According to investigators, Dr. Trey Sunderland, a branch chief with the National Institute of Mental Health, received about $300,000 from Pfizer in return for access to the samples. The report concludes that this case demonstrates a lack of research oversight at the NIH.
The inquiry began after researcher Dr. Susan Molchan became suspicious when she discovered that many of the samples she had collected from patients were missing. The news comes at a time when questions are growing about the integrity of the national tissue supply following the scandal at Biomedical Tissue Services.
- read this Wall Street Journal article (sub. req.)
Related Stories
- ALSO NOTED: Chinese healthcare overhaul creates opportunity; CDHP/HSA critics abound; and much more...
- FDA investigates blindness link in Viagra
- Pfizer gets into stem cell research
- Medicare overpaid for prescription drugs with generic versions
- FDA panel votes against black box for epilepsy meds
- SPOTLIGHT: Pharmas focusing on pet psych meds
- Drugmakers agree to six-month DTC delay
- Harvard psychiatrists fail to reveal millions in pharma pay
- Express Scripts pays $9.5M settlement over drug switching
- SPOTLIGHT: Pfizer, GSK hike prices to boost sales
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceSarbox | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceBiotech | FierceBioResearcher | FiercePharma | FierceVaccines | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2008 FierceMarkets, Inc. All rights reserved. |
![]() |





